4th Quarter - Amendment

THORN RUN PARTNERS for NOVARTIS CORPORATION

Firm
Client
Income
$70,000
Expenses
—

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
4th Quarter - Report Jan 17, 2016 $50,000 Replaced
4th Quarter - Amendment (this page) Apr 19, 2016 $70,000 Yes

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Implementation issues related to the Patient Protection and Affordable Care Act (P.L. 111-148). S.2041, Promoting Life-Saving New Therapies for Neonates Act of 2015; neonatal drug issues.

LobbyistCovered position, as disclosed
ALEX DELPIZZO —
WILLIAM CHRISTOPHER LAMOND —
ANDREW ROSENBERG —
RICHARD CHARLES WHITE —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 2041 (114th)

Taxation/Internal Revenue Code TAX

H.R.3618, Orphan Drug Fairness Act; P.L.114-113, Protecting Americans from Tax Hikes Act of 2015 and Consolidated Appropriations Act, 2016; issues related to the Orphan Drug Tax.

LobbyistCovered position, as disclosed
ALEX DELPIZZO —
WILLIAM CHRISTOPHER LAMOND —
ANDREW ROSENBERG —
RICHARD CHARLES WHITE —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 3618 (114th)

Medicare/Medicaid MMM

Implementation issues related to the Patient Protection and Affordable Care Act (P.L. 111-148).

LobbyistCovered position, as disclosed
ALEX DELPIZZO —
WILLIAM CHRISTOPHER LAMOND —
ANDREW ROSENBERG —
RICHARD CHARLES WHITE —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Medical/Disease Research/Clinical Labs MED

Issues related to biologics.

LobbyistCovered position, as disclosed
ALEX DELPIZZO —
WILLIAM CHRISTOPHER LAMOND —
ANDREW ROSENBERG —
RICHARD CHARLES WHITE —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.